Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

433
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
433
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

301
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
301
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.4K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.4K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

893
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
893
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

245
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
245
Pharmacokinetic–Pharmacodynamic Relationship: Model Components01:14

Pharmacokinetic–Pharmacodynamic Relationship: Model Components

86
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
86

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The adipose tissue-plaque crosstalk: omics profiling of perivascular adipose tissues for understanding plaque stability.

Cardiovascular diabetology·2026
Same author

Beyond weight loss: How metabolism in human adipocytes is shaped by GLP-1R agonists and dual GIPR/GLP-1R agonists.

Pharmacological research·2026
Same author

De Novo Engineered Living Materials via Elastin-Like Polypeptide-Mediated Self-Assembly.

ACS synthetic biology·2026
Same author

Pharmacological Effects of Angiotensin 1-7 on Venous Vascular Tone.

Biomedicines·2026
Same author

Lead sources in seagrass sediments deciphered by isotopic signatures: Implications for organic matter-regulated accumulation.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Model-Based Design of Sustained-Release Formulations of Anti-TNF-α Monoclonal Antibodies for Intravitreal Administration.

Pharmaceutics·2026

Related Experiment Video

Updated: Mar 12, 2026

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver
14:28

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver

Published on: June 27, 2025

1.2K

Leveraging Two-Stage δ Global Sensibility Analysis Method to Inform Parameter Estimation in PBPK Models.

Marina Cuquerella-Gilabert1,2,3,4, Alessandro De Carlo4, Sergio Sánchez Herrero3

  • 1Department of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Valencia, Spain.

Pharmaceutical Statistics
|March 10, 2026
PubMed
Summary

This study introduces a computational framework linking PhysPK and Python for advanced PBPK model analysis. It integrates Global Sensitivity Analysis (GSA) and individual parameter estimation, improving pharmacokinetic modeling accuracy.

Keywords:
PBPKestimationglobal sensitivity analysisparameter estimationsampling strategiestwo‐stage δ GSAuncertainty

More Related Videos

A Modeling and Simulation Method for Preliminary Design of an Electro-Variable Displacement Pump
09:04

A Modeling and Simulation Method for Preliminary Design of an Electro-Variable Displacement Pump

Published on: June 1, 2022

3.7K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

775

Related Experiment Videos

Last Updated: Mar 12, 2026

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver
14:28

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver

Published on: June 27, 2025

1.2K
A Modeling and Simulation Method for Preliminary Design of an Electro-Variable Displacement Pump
09:04

A Modeling and Simulation Method for Preliminary Design of an Electro-Variable Displacement Pump

Published on: June 1, 2022

3.7K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

775

Area of Science:

  • Pharmacokinetics and Pharmacometrics
  • Computational Biology and Bioinformatics
  • Systems Biology

Background:

  • Physiologically Based Pharmacokinetic (PBPK) modeling is crucial for drug development but often lacks robust methods for sensitivity analysis and parameter estimation.
  • Current practices inadequately address Global Sensitivity Analysis (GSA) and individual parameter refinement, limiting PBPK model accuracy and applicability.

Purpose of the Study:

  • To establish a computational framework integrating PhysPK and Python for advanced PBPK analysis.
  • To implement Two-stage delta GSA and iterative two-stage (ITS) methods for semi-mechanistic PBPK models.
  • To assess the impact of parameter uncertainty and correlations on key pharmacokinetic endpoints.

Main Methods:

  • Developed a framework linking PhysPK with Python for GSA and parameter estimation.
  • Applied Two-stage delta GSA to identify influential parameters affecting AUC, Cmax, and Tmax.
  • Utilized the ITS method for individual parameter estimation across various simulated scenarios and optimization algorithms (Nelder-Mead, Powell, BFGS).

Main Results:

  • Two-stage delta GSA identified volume of distribution, clearance, and gastric emptying rate as key parameters.
  • Parameter estimation performance was evaluated using AFE, AAFE, and PEE metrics.
  • Most estimations achieved AFE and AAFE values between 0.8 and 1.25, with Nelder-Mead showing superior accuracy.

Conclusions:

  • The integrated framework successfully combines correlation-aware GSA with individual parameter estimation in PBPK models.
  • This approach enhances PBPK model simplification and supports data-constrained individual parameter estimation.
  • The integration represents a significant advancement for the PhysPK platform, offering a powerful tool for pharmacokinetic modeling.